CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Director sold 1,900,036 shares at $4.18 ($7,942,150)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 235,467 shares at $3.63 ($855,899)
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 2,966,293 shares at an average $4.14 ($12,291,748)
- 144 Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Director sold 174,360 shares at an average $3.47 ($604,192)
- 4 Open-market sale Director sold 1,809,667 shares at $3.41 ($6,170,964)
- 144 Insider Sale of Securities
Page 5 of 67 · 1,325 filings